TECH Bio-Techne Corp - Common Stock
NASDAQ · Life Sciences Tools & Services · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 24, 2026
$72,40
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$43,2052 haftanın en düşüğü
$72,6952 haftanın en yükseği
Piyasa Değeri (MRQ)
$11.30B
P/E (TTM)
62.4
Hisse Başına Kâr (TTM)
$1.16
Gelir (TTM)
$1.22B
rozetleriniz
52 Haftlık Aralık
$43–$73
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$71
P/E
62.4
ROE
9.0%
Net Kâr Marjı
15.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TECH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$72.40
Piyasa Değeri (MRQ)
$11.30B
P/E (TTM)
62.4
Hisse Başına Kâr (TTM)
$1.16
Gelir (TTM)
$1.22B
Temettü Verimi
0.44%
ROE (TTM)
9.0%
52 Haftlık Aralık
$43–$73
TECH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 30 Kasım 2022 | 4-for-1 | İleri |
| 04 Aralık 2000 | 2-for-1 | İleri |
| 18 Kasım 1997 | 2-for-1 | İleri |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$1.22B2017-06-30 → 2026-06-30
Hisse Başına Kâr$1.162017-06-30 → 2026-06-30
Serbest Nakit Akışı$263M2017-06-30 → 2026-06-30
Net kar marjı15.0%2017-06-30 → 2026-06-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TECH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 62.45Y ort. ≈67.9 | ≈67.9 | 46.0 | Aşırı değerli | |
| F/S (TTM) | 9.35Y ort. ≈8.0 | ≈8.0 | 4.9 | Aşırı değerli | |
| F/D (MRQ) | 5.45Y ort. ≈4.7 | ≈4.7 | 3.6 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 42.95Y ort. ≈38.5 | ≈38.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 38.75Y ort. ≈32.9 | ≈32.9 | 26.2 | Aşırı değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 6.35Y ort. ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio (PEG Oranı) | ≈10.5 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TECH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 65.8%5Y ort. ≈66.6% | ≈66.6% | 45.9% | En üst düzey | |
| Faaliyet Kâr Marjı (TTM) | 20.7%5Y ort. ≈20.0% | ≈20.0% | 12.1% | En üst düzey | |
| FAVÖK Marjı (TTM) | 28.7%5Y ort. ≈29.1% | ≈29.1% | 14.8% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 19.8%5Y ort. ≈20.2% | ≈20.2% | 12.4% | En üst düzey | |
| Net Kâr Marjı (TTM) | 15.0%5Y ort. ≈17.0% | ≈17.0% | 10.8% | En üst düzey | |
| ROA (TTM) | 7.1%5Y ort. ≈7.9% | ≈7.9% | 2.0% | En üst düzey | |
| ROE (TTM) | 9.0%5Y ort. ≈10.6% | ≈10.6% | 3.3% | En üst düzey | |
| ROIC | 9.0%5Y ort. ≈10.0% | ≈10.0% | 3.0% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TECH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 4.55Y ort. ≈4.0 | ≈4.0 | 1.8 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 2.95Y ort. ≈2.6 | ≈2.6 | 1.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | TECH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -0.38%5Y ort. ≈5.7% | ≈5.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 2.2%5Y ort. ≈7.2% | ≈7.2% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 5.5% | · | · | · | |
| EPS YoY (EPS YB) | 152.2%5Y ort. ≈30.5% | ≈30.5% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 147.8%5Y ort. ≈29.8% | ≈29.8% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -13.0%5Y ort. ≈-18.5% | ≈-18.5% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 5.9% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -13.9%5Y ort. ≈-8.9% | ≈-8.9% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 5.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | TECH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.55Y ort. ≈0.5 | ≈0.5 | 0.5 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 2.25Y ort. ≈2.4 | ≈2.4 | 2.2 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.75Y ort. ≈5.6 | ≈5.6 | 5.6 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$405.0K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi0.44%
Temettü Ödeme Oranı27.5%
Yıllıklaştırılmış Ödeme≈$0.32
5 Yıllık Temettü CAGR≈0.00%
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ağu 24, 2026 | $0,08 | USD | ≈0.44% |
| May 18, 2026 | $0,08 | USD | ≈0.72% |
| Şub 13, 2026 | $0,08 | USD | ≈0.53% |
| Kas 17, 2025 | $0,08 | USD | ≈0.55% |
| Ağu 18, 2025 | $0,08 | USD | ≈0.60% |
| May 19, 2025 | $0,08 | USD | ≈0.65% |
| Şub 14, 2025 | $0,08 | USD | ≈0.49% |
| Kas 8, 2024 | $0,08 | USD | ≈0.42% |
| Ağu 19, 2024 | $0,08 | USD | ≈0.43% |
| May 10, 2024 | $0,08 | USD | ≈0.40% |
| Şub 9, 2024 | $0,08 | USD | ≈0.47% |
| Kas 9, 2023 | $0,08 | USD | ≈0.56% |
| Ağu 17, 2023 | $0,08 | USD | ≈0.40% |
| May 12, 2023 | $0,08 | USD | ≈0.39% |
| Şub 10, 2023 | $0,08 | USD | ≈0.42% |
| Kas 10, 2022 | $0,08 | USD | ≈0.38% |
| Ağu 12, 2022 | $0,08 | USD | ≈0.34% |
| May 13, 2022 | $0,08 | USD | ≈0.35% |
| Şub 10, 2022 | $0,08 | USD | ≈0.30% |
| Kas 10, 2021 | $0,08 | USD | ≈0.25% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
1.4%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $0.52 | $0.53 | -1.8% | |
| 31 Mart 2026 | $0.53 | $0.55 | -3.3% | |
| 31 Aralık 2025 | $0.46 | $0.44 | 4.0% | |
| 30 Eylül 2025 | $0.42 | $0.43 | -2.0% | |
| 30 Haziran 2025 | $0.53 | $0.51 | 4.1% | |
| 31 Mart 2025 | $0.56 | $0.52 | 7.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | |
| Cost of Revenue | $416M | $429M | $389M | $367M | $349M | $298M | $255M | $241M | $211M | $188M | $162M | $145M | |
| Gross Profit | $799M | $790M | $770M | $770M | $756M | $633M | $483M | $473M | $432M | $375M | $337M | $307M | |
| SG&A Expense | $452M | $589M | $466M | $378M | $373M | $325M | $261M | $264M | $241M | $200M | $141M | $119M | |
| Operating Expenses | $547M | $688M | $563M | $471M | $460M | $396M | $326M | $327M | $296M | $254M | $186M | $160M | |
| Operating Income | $252M | $102M | $207M | $299M | $297M | $237M | $157M | $147M | $136M | $121M | $151M | $147M | |
| Interest Expense | · | · | · | $11M | $11M | $14M | $19M | $22M | $10M | $7M | $2M | $2M | |
| Other Non-op | $-6M | $831.0K | $-9M | $48M | $15M | $-76M | $138M | $-14M | $-447.0K | $-2M | $-2M | $8M | |
| Pretax Income | $241M | $98M | $186M | $339M | $301M | $148M | $276M | $112M | $126M | $112M | $147M | $154M | |
| Income Tax | $59M | $25M | $18M | $53M | $38M | $9M | $47M | $16M | $-198.0K | $36M | $43M | $46M | |
| Net Income | $182M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $126M | $76M | $104M | $108M | |
| EPS (Basic) | $1.17 | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 | $6.00 | $2.54 | $3.36 | $2.04 | $2.81 | $2.90 | |
| EPS (Diluted) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 | |
| Shares (Basic) | 155,963,000 | 157,521,000 | 157,708,000 | 157,179,000 | 156,874,000 | 154,986,000 | 38,201,000 | 37,781,000 | 37,476,000 | 37,313,000 | 37,194,000 | 37,096,000 | |
| Shares (Diluted) | 157,009,000 | 159,717,000 | 160,774,000 | 161,855,000 | 164,114,000 | 161,932,000 | 39,401,000 | 38,892,000 | 38,055,000 | 37,500,000 | 37,326,000 | 37,231,000 | |
| EBITDA | $349M | $212M | $318M | $406M | $398M | $325M | $240M | $225M | $201M | $181M | $193M | $37M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $265M | $162M | $152M | $181M | $173M | $199M | $147M | $101M | $122M | $92M | $64M | $55M | |
| Short-term Investments | · | · | $1M | $24M | $74M | $32M | $124M | $65M | $60M | $66M | $32M | $56M | |
| Receivables | $217M | $207M | $241M | $218M | $195M | $145M | $123M | $137M | $120M | $117M | $93M | $70M | |
| Inventory | $196M | $189M | $180M | $172M | $141M | $117M | $103M | $91M | $86M | $86M | $57M | $50M | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | $13M | $8M | $5M | |
| Other Current Assets | $67M | $37M | $34M | $27M | $23M | $17M | $24M | $18M | $11M | $13M | $8M | $6M | |
| Current Assets | $744M | $608M | $617M | $621M | $606M | $511M | $521M | $413M | $398M | $348M | $254M | $248M | |
| PP&E (Net) | $232M | $246M | $251M | $226M | $223M | $208M | $177M | $154M | $145M | $135M | $132M | $130M | |
| PP&E (Gross) | $540M | $532M | $508M | $460M | $435M | $398M | $347M | $306M | $285M | $263M | $246M | $239M | |
| Accum. Depreciation | $308M | $286M | $257M | $234M | $211M | $190M | $170M | $152M | $139M | $128M | $114M | $109M | |
| Goodwill | $975M | $981M | $973M | $873M | $822M | $843M | $728M | $733M | $598M | $579M | $431M | $391M | |
| Intangibles | $303M | $366M | $507M | $535M | $532M | $616M | $517M | $579M | $446M | $452M | $311M | $293M | |
| Other Non-current Assets | $264M | $284M | $264M | $285M | $47M | $12M | $14M | $6M | $5M | $44M | $2M | $2M | |
| Total Assets | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B | $1.13B | $1.06B | |
| Accounts Payable | $27M | $25M | $38M | $26M | $34M | $29M | $23M | $16M | $18M | $17M | $21M | $13M | |
| Accrued Liabilities | $20M | $26M | $25M | $15M | $18M | $15M | $9M | $26M | $20M | $19M | $8M | $7M | |
| Current Liabilities | $164M | $176M | $159M | $129M | $176M | $152M | $107M | $102M | $80M | $136M | $54M | $40M | |
| Capital Leases | $74M | $84M | $88M | $94M | $58M | $68M | $67M | $0 | · | · | · | · | |
| Deferred Tax | $19M | $6M | $56M | $89M | $99M | $93M | $101M | $90M | $86M | $121M | $63M | $61M | |
| Other Non-current Liabilities | $21M | $27M | $13M | $11M | $12M | $24M | $27M | $25M | $9M | $5M | $3M | $3M | |
| Total Debt | · | · | · | · | $12M | $12M | $12M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $390.0K | $385.0K | $379.0K | $376.0K | $374.0K | $372.0K | $371.0K | |
| Retained Earnings | $1.14B | $1.07B | $1.33B | $1.31B | $1.12B | $1.09B | $1.06B | $932M | $877M | $799M | $771M | $714M | |
| AOCI | $-71M | $-60M | $-78M | $-66M | $-75M | $-57M | $-97M | $-84M | $-45M | $-49M | $-70M | $-31M | |
| Stockholders' Equity | $2.11B | $1.92B | $2.07B | $1.97B | $1.70B | $1.56B | $1.38B | $1.17B | $1.08B | $950M | $879M | $847M | |
| Liabilities + Equity | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B | $1.13B | $1.06B | |
| Shares Outstanding | 156,095,113 | 154,972,196 | 158,216,000 | 157,642,000 | 156,644,000 | 155,822,000 | 153,812,000 | 37,934,000 | 37,608,000 | 37,356,000 | 37,254,000 | 37,153,000 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $97M | $110M | $112M | $107M | $101M | $88M | $83M | $78M | $64M | $60M | $43M | $37M | |
| Stock-based Comp | $41M | $41M | $38M | $39M | $42M | $49M | $32M | $32M | $28M | $15M | $9M | $6M | |
| Deferred Tax | $24M | $-51M | $-40M | $-30M | $7M | $-28M | $14M | $-14M | $-46M | $-5M | $-3M | $1M | |
| Amort. of Intangibles | $62M | $76M | $80M | $77M | $74M | $65M | $61M | $59M | $47M | $44M | $29M | · | |
| Restructuring | · | · | $12M | $4M | $2M | $142.0K | $87.0K | · | $376.0K | · | · | · | |
| Other Non-cash | $-52M | $115M | $21M | $-148M | $-97M | $103M | $-153M | $-11M | $-2M | $-4M | $-10M | $-13M | |
| Operating Cash Flow | $292M | $288M | $299M | $254M | $325M | $352M | $205M | $182M | $170M | $144M | $144M | $139M | |
| CapEx | $29M | $31M | $63M | $38M | $45M | $44M | $52M | $25M | $21M | $15M | $17M | $20M | |
| Investing Cash Flow | $-18M | $-35M | $-203M | $-266M | $-97M | $-244M | $27M | $-337M | $-39M | $-306M | $-108M | · | |
| Stock Repurchased | $42M | $276M | $80M | $20M | $161M | $43M | $50M | $15M | $0 | · | · | $0 | |
| Net Stock Activity | $-42M | $-276M | $-80M | $-20M | $-161M | $-43M | $-50M | $-15M | · | · | · | $0 | |
| Dividends Paid | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M | |
| Financing Cash Flow | $-169M | $-254M | $-122M | $23M | $-243M | $-63M | $-184M | $134M | $-99M | $189M | $-23M | · | |
| Net Change in Cash | $103M | $10M | $-29M | $8M | $-27M | $52M | $46M | $-21M | $30M | $27M | $10M | $-264M | |
| Taxes Paid | $64M | $74M | $65M | $88M | $30M | $21M | $42M | $37M | $35M | $43M | $45M | $43M | |
| Free Cash Flow | $263M | $257M | $236M | $216M | $280M | $308M | $153M | $156M | $149M | $128M | $127M | $119M | |
| Levered FCF | · | · | · | $207M | $270M | $295M | $138M | $138M | $139M | $123M | $126M | $118M |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% | 67.9% | |
| Operating Margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% | 30.2% | 0.03% | |
| Net Margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% | 20.9% | 23.8% | |
| Pretax Margin | 19.8% | 8.1% | 16.0% | 29.8% | 27.3% | 15.9% | 37.4% | 15.7% | 19.6% | 19.9% | 29.5% | 34.1% | |
| EBITDA Margin | 28.7% | 17.4% | 27.5% | 35.7% | 36.0% | 34.9% | 32.5% | 31.5% | 31.2% | 32.1% | 38.8% | 8.3% | |
| ROA | 7.1% | 2.8% | 6.3% | 11.6% | 11.9% | 6.6% | 11.7% | · | 8.0% | 5.7% | 9.5% | 11.2% | |
| ROE | 9.0% | 3.7% | 8.2% | 15.6% | 16.7% | 9.5% | 17.0% | · | 11.8% | 8.3% | 12.1% | 13.1% | |
| ROIC | 9.0% | 4.0% | 9.0% | 12.8% | 15.1% | 14.2% | 9.4% | · | 12.6% | 8.6% | 12.1% | 0.01% |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 3.5 | 3.9 | 4.8 | 3.4 | 3.4 | 4.9 | · | 5.0 | 2.6 | 4.7 | 6.2 | |
| Quick Ratio | 2.9 | 2.1 | 2.5 | 3.3 | 2.1 | 2.5 | 3.7 | · | 3.8 | 2.0 | 3.5 | 4.6 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | 26.7 | 26.2 | 17.0 | 8.2 | 6.8 | 13.4 | 16.4 | 86.2 | 0.1 |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 2.2 | 2.3 | 2.2 | 2.3 | 2.7 | 2.7 | 2.6 | · | 2.5 | 3.2 | 3.0 | 3.3 | |
| Receivables Turnover | 5.7 | 5.4 | 5.0 | 5.5 | 6.5 | 7.0 | 5.7 | · | 5.4 | 5.4 | 6.1 | 7.2 |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.51 | $12.38 | $13.08 | $12.47 | $43.46 | $40.12 | $35.92 | · | $28.69 | $25.42 | $23.60 | $22.80 | |
| Revenue / Share | $7.74 | $7.64 | $7.21 | $7.02 | $26.95 | $23.00 | $18.75 | $18.36 | $16.90 | $15.01 | $13.37 | $12.15 | |
| Cash Flow / Share | $1.86 | $1.80 | $1.86 | $1.57 | $7.93 | $8.70 | $5.21 | $4.67 | $4.48 | $3.83 | $3.85 | $3.74 | |
| Cash / Share | $1.70 | $1.05 | $0.96 | $1.15 | $4.41 | $5.11 | $3.81 | · | $3.24 | $2.45 | $1.72 | $1.47 | |
| Dividend / Share | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $1.28 | $1.28 | $1.28 | $1.28 | · | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $1.28 | $1.28 | $1.28 | $1.27 | |
| EPS (TTM) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.38% | 5.2% | 2.0% | 2.8% | 18.8% | 26.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | 3.3% | 7.6% | 15.4% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.5% | 10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 152.2% | -56.2% | -40.3% | 6.0% | 90.8% | -85.0% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | -34.8% | 6.5% | -32.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.9% | -39.8% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 147.8% | -56.3% | -41.1% | 4.9% | 93.8% | -38.8% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -13.9% | -35.4% | 6.2% | 7.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | -20.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.12% | 0.60% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | |
| Net Income TTM | $182M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $126M | $76M | $104M | $108M | |
| Market Cap | $11.03B | $7.97B | $11.34B | $12.87B | $3.39B | $4.39B | $2.54B | · | $1.39B | $1.10B | $1.05B | $915M | |
| Enterprise Value | · | · | · | · | $3.23B | $4.17B | $2.28B | · | · | · | · | · | |
| P/E | 60.9 | 111.8 | 68.2 | 46.4 | 52.2 | 129.4 | 11.3 | 21.1 | 11.2 | 14.5 | 10.1 | 8.5 | |
| P/S | 9.1 | 6.5 | 9.8 | 11.3 | 3.1 | 4.7 | 3.4 | · | 2.2 | 1.9 | 2.1 | 2.0 | |
| P/B | 5.2 | 4.2 | 5.5 | 6.5 | 2.0 | 2.8 | 1.8 | · | 1.3 | 1.2 | 1.2 | 1.1 | |
| P / Tangible Book | 13.3 | 13.9 | 19.2 | 23.0 | 9.8 | 42.2 | 18.6 | · | · | · | · | · | |
| P / Cash Flow | 37.8 | 27.7 | 37.9 | 50.6 | 10.4 | 12.5 | 12.4 | · | 8.2 | 7.6 | 7.3 | 6.6 | |
| P / FCF | 41.9 | 31.1 | 48.0 | 59.5 | 12.1 | 14.2 | 16.5 | · | 9.3 | 8.6 | 8.3 | 7.7 | |
| EV / EBITDA | · | · | · | · | 8.1 | 12.8 | 9.5 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | 11.5 | 13.5 | 14.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 2.9 | 4.5 | 3.1 | · | · | · | · | · | |
| Dividend Yield | 0.45% | 0.63% | 0.44% | 0.39% | 1.5% | 1.1% | 1.9% | · | 3.5% | 4.3% | 4.5% | 5.1% | |
| Earnings Yield | 1.6% | 0.89% | 1.5% | 2.2% | 1.9% | 0.77% | 8.8% | 4.7% | 8.9% | 6.9% | 9.9% | 11.7% | |
| Payout Ratio | 27.5% | 68.7% | 30.0% | 17.6% | 18.4% | 35.3% | 21.3% | 50.3% | 38.0% | 62.2% | 45.6% | 43.7% | |
| Annual Payout | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M |
Gelir Tablosu
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321M | $311M | $296M | $287M | $317M | $316M | $297M | $289M | $306M | $303M | $273M | $277M | $301M | $294M | $272M | $270M | |
| Cost of Revenue | $110M | $103M | $105M | $98M | $118M | $102M | $103M | $106M | $103M | $99M | $96M | $92M | $97M | $92M | $88M | $90M | |
| Gross Profit | $211M | $208M | $191M | $188M | $199M | $215M | $194M | $183M | $203M | $205M | $177M | $185M | $205M | $202M | $183M | $180M | |
| SG&A Expense | $113M | $109M | $114M | $116M | $197M | $151M | $121M | $119M | $134M | $112M | $116M | $105M | $87M | $99M | $93M | $99M | |
| Operating Expenses | $137M | $133M | $137M | $140M | $223M | $176M | $146M | $143M | $158M | $138M | $139M | $129M | $110M | $122M | $115M | $123M | |
| Operating Income | $74M | $75M | $54M | $48M | $-24M | $39M | $47M | $40M | $46M | $67M | $38M | $56M | $95M | $80M | $68M | $56M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | $4M | $5M | · | $1M | $2M | $4M | |
| Other Non-op | $2M | $-4M | $-4M | $333.0K | $6M | $-434.0K | $-5M | $184.0K | $8M | $-6M | $-5M | $-6M | $2M | $-15.0K | $-1M | $47M | |
| Pretax Income | $71M | $71M | $51M | $48M | $-23M | $38M | $43M | $40M | $42M | $61M | $33M | $50M | $88M | $80M | $66M | $104M | |
| Income Tax | $16M | $20M | $13M | $10M | $-5M | $16M | $8M | $7M | $1M | $12M | $6M | $-1M | $13M | $10M | $16M | $14M | |
| Net Income | $55M | $51M | $38M | $38M | $-18M | $23M | $35M | $34M | $41M | $49M | $27M | $51M | $75M | $70M | $50M | $90M | |
| EPS (Basic) | $0.35 | $0.33 | $0.24 | $0.25 | $-0.10 | $0.14 | $0.22 | $0.21 | $0.27 | $0.31 | $0.17 | $0.32 | $0.47 | $0.45 | $0.32 | $0.57 | |
| EPS (Diluted) | $0.36 | $0.32 | $0.24 | $0.24 | $-0.11 | $0.14 | $0.22 | $0.21 | $0.26 | $0.31 | $0.17 | $0.31 | $0.47 | $0.43 | $0.31 | $0.55 | |
| Shares (Basic) | · | 156,327,000 | 155,839,000 | 155,464,000 | · | 157,372,000 | 158,431,000 | 158,531,000 | · | 157,309,000 | 157,533,000 | 158,130,000 | · | 157,311,000 | 157,011,000 | 156,929,000 | |
| Shares (Diluted) | · | 157,403,000 | 156,999,000 | 156,362,000 | · | 158,944,000 | 160,626,000 | 161,115,000 | · | 160,496,000 | 160,060,000 | 161,940,000 | · | 161,615,000 | 161,750,000 | 162,172,000 | |
| EBITDA | · | $75M | $54M | $72M | · | $39M | $47M | $68M | · | $67M | $38M | $84M | · | $80M | $68M | $83M |
Bilanço
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $265M | $210M | $173M | $145M | $162M | $141M | $178M | $188M | $152M | $140M | $130M | $149M | · | $127M | $165M | $165M | |
| Short-term Investments | · | · | · | · | · | $0 | $0 | · | $1M | $5M | $6M | · | · | $30M | $32M | $38M | |
| Receivables | $217M | $215M | $185M | $184M | $207M | $237M | $218M | $224M | $241M | $228M | $207M | $205M | · | $216M | $185M | $174M | |
| Inventory | $196M | $201M | $205M | $203M | $189M | $191M | $188M | $185M | $180M | $179M | $181M | $186M | · | $169M | $160M | $150M | |
| Other Current Assets | $67M | $62M | $74M | $77M | $37M | $54M | $50M | $43M | $34M | $31M | $40M | $52M | · | $28M | $23M | $25M | |
| Current Assets | $744M | $688M | $637M | $610M | $608M | $627M | $635M | $649M | $617M | $611M | $591M | $591M | · | $571M | $565M | $552M | |
| PP&E (Net) | $232M | $233M | $234M | $240M | $246M | $252M | $250M | $254M | $251M | $244M | $234M | $232M | · | $224M | $224M | $224M | |
| PP&E (Gross) | $540M | $534M | $527M | $529M | $532M | $531M | $520M | $519M | $508M | $496M | $479M | $473M | · | $454M | $447M | $440M | |
| Accum. Depreciation | $308M | $301M | $293M | $289M | $286M | $279M | $270M | $265M | $257M | $252M | $245M | $241M | · | $230M | $223M | $216M | |
| Goodwill | $975M | $978M | $981M | $979M | $981M | $969M | $965M | $983M | $973M | $971M | $980M | $969M | $873M | $871M | $870M | $865M | |
| Intangibles | $303M | $319M | $335M | $350M | $366M | $444M | $461M | $486M | $507M | $526M | $551M | $579M | $535M | $553M | $568M | $586M | |
| Other Non-current Assets | $264M | $264M | $267M | $277M | $284M | $269M | $275M | $276M | $264M | $272M | $274M | $282M | · | $283M | $53M | $54M | |
| Total Assets | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B | $2.73B | $2.76B | · | $2.60B | $2.36B | $2.35B | |
| Accounts Payable | $27M | $23M | $26M | $30M | $25M | $32M | $33M | $32M | $38M | $29M | $32M | $28M | · | $27M | $24M | $30M | |
| Accrued Liabilities | $20M | $18M | $20M | $19M | $26M | $24M | $28M | $21M | $25M | $18M | $17M | $16M | · | $16M | $16M | $14M | |
| Current Liabilities | $164M | $153M | $140M | $145M | $176M | $169M | $161M | $142M | $159M | $150M | $135M | $128M | · | $141M | $128M | $138M | |
| Capital Leases | $74M | $76M | $77M | $81M | $84M | $79M | $82M | $85M | $88M | $93M | $96M | $97M | · | $93M | $78M | $65M | |
| Deferred Tax | $19M | $14M | $11M | $11M | $6M | $32M | $38M | $50M | $56M | $64M | $72M | $83M | · | $95M | $111M | $113M | |
| Other Non-current Liabilities | $21M | $22M | $23M | $24M | $27M | $16M | $11M | $20M | $13M | $12M | $17M | $9M | · | $11M | $11M | $12M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $392.0K | |
| Retained Earnings | $1.14B | $1.15B | $1.11B | $1.08B | $1.07B | $1.20B | $1.29B | $1.34B | $1.33B | $1.30B | $1.26B | $1.33B | · | $1.25B | $1.20B | $1.16B | |
| AOCI | $-71M | $-67M | $-62M | $-64M | $-60M | $-82M | $-86M | $-60M | $-78M | $-75M | $-64M | $-78M | · | $-74M | $-75M | $-92M | |
| Stockholders' Equity | $2.11B | $2.09B | $2.01B | $1.97B | $1.92B | $2.02B | $2.08B | $2.14B | $2.07B | $2.01B | $1.96B | $2.00B | $1.97B | $1.89B | $1.83B | $1.75B | |
| Liabilities + Equity | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B | $2.73B | $2.76B | · | $2.60B | $2.36B | $2.35B | |
| Shares Outstanding | 156,095,113 | 156,516,091 | 155,881,291 | 155,749,477 | 154,972,196 | 156,760,717 | 157,915,999 | 158,878,127 | 158,216,000 | 157,554,366 | 157,142,004 | 158,354,579 | 157,642,000 | 157,339,318 | 157,093,879 | 39,232,094 |
Nakit Akışı
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $25M | $24M | $27M | $28M | $27M | $28M | $28M | $27M | $28M | $29M | $27M | $27M | $27M | $27M | |
| Stock-based Comp | $5M | $10M | $14M | $12M | $5M | $11M | $15M | $10M | $7M | $8M | $13M | $10M | $-2M | $10M | $17M | $14M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $4M | |
| Amort. of Intangibles | $15M | $16M | $16M | $15M | $18M | $19M | $19M | $20M | $20M | $20M | $20M | $20M | · | $20M | $19M | $20M | |
| Restructuring | · | · | · | · | · | · | · | · | $21M | $1M | $11M | · | · | · | · | · | |
| Other Non-cash | · | · | · | $-47M | · | · | · | $-8M | · | · | · | $-34M | · | · | · | $-75M | |
| Operating Cash Flow | $95M | $87M | $82M | $28M | $98M | $41M | $84M | $64M | $75M | $81M | $83M | $59M | $83M | $51M | $64M | $56M | |
| CapEx | $8M | $9M | $6M | $5M | $5M | $10M | $7M | $9M | $18M | $16M | $15M | $14M | $11M | $12M | $6M | $10M | |
| Investing Cash Flow | $-7M | $-6M | $-6M | $605.0K | $406.0K | $-9M | $-5M | $-22M | $-9M | $-16M | $-24M | $-154M | $-5M | $-241M | $-109.0K | $-20M | |
| Stock Repurchased | $42M | $0 | $0 | $24.0K | $100M | $100M | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $20M | |
| Net Stock Activity | · | · | · | $-24.0K | · | · | · | · | · | · | · | · | · | · | · | $-20M | |
| Dividends Paid | $12M | $13M | $12M | $12M | $12M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | |
| Financing Cash Flow | $-33M | $-43M | $-49M | $-44M | $-90M | $-68M | $-84M | $-12M | $-60M | $-52M | $-81M | $72M | $-24M | $151M | $-72M | $-32M | |
| Net Change in Cash | $55M | $37M | $28M | $-17M | $22M | $-37M | $-10M | $36M | $12M | $10M | $-19M | $-32M | $53M | $-37M | $-575.0K | $-7M | |
| Free Cash Flow | · | · | · | $22M | · | · | · | $55M | · | · | · | $46M | · | · | · | $47M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $41M | · | · | · | $43M |
Kârlılık
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 66.9% | 64.6% | 65.6% | · | 67.9% | 65.3% | 63.2% | · | 67.4% | 64.8% | 66.9% | · | 68.7% | 67.5% | 66.6% | |
| Operating Margin | · | 24.2% | 18.4% | 16.6% | · | 12.2% | 16.0% | 13.8% | · | 22.1% | 13.9% | 20.2% | · | 27.3% | 25.0% | 20.9% | |
| Net Margin | · | 16.4% | 12.8% | 13.3% | · | 7.1% | 11.8% | 11.6% | · | 16.2% | 10.1% | 18.4% | · | 23.9% | 18.4% | 33.2% | |
| Pretax Margin | · | 22.9% | 17.2% | 16.8% | · | 12.1% | 14.4% | 13.9% | · | 20.1% | 12.2% | 17.9% | · | 27.3% | 24.5% | 38.5% | |
| EBITDA Margin | · | 24.2% | 18.4% | 25.1% | · | 12.2% | 16.0% | 23.5% | · | 22.1% | 13.9% | 30.5% | · | 27.3% | 25.0% | 30.8% | |
| ROA | · | 2.0% | 1.5% | 1.5% | · | 0.84% | 1.3% | 1.2% | · | 1.8% | 1.1% | 2.0% | · | 2.9% | 2.1% | 3.9% | |
| ROE | · | 2.5% | 1.9% | 1.9% | · | 1.1% | 1.7% | 1.6% | · | 2.5% | 1.5% | 2.7% | · | 3.9% | 2.8% | 5.3% | |
| ROIC | · | 2.6% | 2.0% | 1.9% | · | 1.1% | 1.9% | 1.6% | · | 2.7% | 1.6% | 2.9% | · | 3.7% | 2.8% | 2.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.5 | 4.5 | 4.2 | · | 3.7 | 3.9 | 4.6 | · | 4.1 | 4.4 | 4.6 | · | 4.0 | 4.4 | 4.0 | |
| Quick Ratio | · | 2.8 | 2.5 | 2.3 | · | 2.2 | 2.5 | 2.9 | · | 2.5 | 2.5 | 2.8 | · | 2.6 | 3.0 | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 16.7 | 8.8 | 11.4 | · | 58.7 | 28.8 | 14.9 |
Verimlilik
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.7 | |
| Receivables Turnover | · | 1.4 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.5 | · | 1.4 | 1.6 | 1.7 |
Hisse Başına
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $13.32 | $12.90 | $12.62 | · | $12.87 | $13.16 | $13.46 | · | $12.79 | $12.50 | $12.62 | · | $12.01 | $11.63 | $44.64 | |
| Revenue / Share | · | $1.98 | $1.88 | $1.83 | · | $1.99 | $1.85 | $1.80 | · | $1.89 | $1.70 | $1.71 | · | $1.82 | $1.68 | $6.65 | |
| Cash Flow / Share | · | · | · | $0.18 | · | · | · | $0.40 | · | · | · | $0.37 | · | · | · | $1.38 | |
| Cash / Share | · | $1.34 | $1.11 | $0.93 | · | $0.90 | $1.12 | $1.18 | · | $0.89 | $0.83 | $0.94 | · | $0.81 | $1.05 | $4.21 | |
| Dividend / Share | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $-0.16 | $0.24 | $0.16 | $0.08 | |
| EPS (TTM) | · | $0.69 | $0.51 | $0.49 | · | $0.83 | $1.00 | $0.95 | · | $1.26 | $1.38 | $1.52 | · | $0.40 | $0.34 | $0.52 |
Değerleme (TTM)
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.21B | $1.22B | $1.22B | · | $1.21B | $1.20B | $1.17B | · | $1.15B | $1.14B | $1.14B | · | $1.12B | $1.12B | $1.12B | |
| Net Income TTM | · | $110M | $81M | $78M | · | $132M | $158M | $151M | · | $203M | $224M | $247M | · | $271M | $262M | $292M | |
| Market Cap | · | $8.18B | $9.17B | $8.66B | · | $9.19B | $11.37B | $12.70B | · | $11.09B | $12.13B | $10.78B | · | $11.67B | $13.02B | $2.79B | |
| P/E | · | 75.7 | 115.3 | 113.5 | · | 70.6 | 72.0 | 84.1 | · | 55.9 | 55.9 | 44.8 | · | 185.5 | 243.8 | 136.5 | |
| P/S | · | 6.8 | 7.5 | 7.1 | · | 7.6 | 9.5 | 10.8 | · | 9.6 | 10.6 | 9.4 | · | 10.4 | 11.6 | 2.5 | |
| P/B | · | 3.9 | 4.6 | 4.4 | · | 4.6 | 5.5 | 5.9 | · | 5.5 | 6.2 | 5.4 | · | 6.2 | 7.1 | 1.6 | |
| P / Tangible Book | · | 10.4 | 13.2 | 13.6 | · | 15.2 | 17.4 | 19.0 | · | 21.5 | 28.0 | 24.0 | · | 25.1 | 33.4 | 9.3 | |
| P / Cash Flow | · | · | · | 314.1 | · | · | · | 198.8 | · | · | · | 181.5 | · | · | · | 49.7 | |
| Dividend Yield | · | 0.61% | 0.54% | 0.58% | · | 0.55% | 0.45% | 0.40% | · | 0.45% | 0.42% | 0.47% | · | 0.43% | 0.39% | 1.8% | |
| Earnings Yield | · | 1.3% | 0.87% | 0.88% | · | 1.4% | 1.4% | 1.2% | · | 1.8% | 1.8% | 2.2% | · | 0.54% | 0.41% | 0.73% | |
| Payout Ratio | · | · | · | 32.6% | · | · | · | 37.8% | · | · | · | 24.8% | · | · | · | 14.0% | |
| Annual Payout | · | $50M | $50M | $50M | · | $51M | $51M | $50M | · | $50M | $50M | $50M | · | $50M | $50M | $50M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Gelir | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B |
| Brüt Kâr Marjı % | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% |
| Faaliyet Kâr Marjı % | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% |
| Net Gelir | $182M | $73M | $168M | $285M | $272M |
| Seyreltilmiş Hisse Başı Kâr | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | · | · | 0.0 |
| Cari Oran | 4.5 | 3.5 | 3.9 | 4.8 | 3.4 |
| Cari Oran | 2.9 | 2.1 | 2.5 | 3.3 | 2.1 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $263M | $257M | $236M | $216M | $280M |
Kurumsal Sahipler (13F) 635 dosya · $13.4B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
635
Tutulan Değer
$13.4B
Yeni pozisyonlar
131
Çıkan pozisyonlar
110
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 131 (+46 önceki Ç'ye göre) | 110 (+52 önceki Ç'ye göre) | 159 (-43 önceki Ç'ye göre) | 248 (+27 önceki Ç'ye göre) | +3.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.047.457.735 | 17.810.878 | 7,84% | Hisse senetleri |
| BlackRock, Inc. | $990.923.913 | 14.025.816 | 7,42% | Hisse senetleri |
| FMR LLC | $903.951.465 | 12.794.784 | 6,77% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $721.941.123 | 10.218.558 | 5,40% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $518.805.868 | 7.343.324 | 3,88% | Hisse senetleri |
| HBK INVESTMENTS L P | $482.186.250 | 6.825.000 | 3,61% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $459.674.334 | 6.506.360 | 3,44% | Hisse senetleri |
| MORGAN STANLEY | $450.374.056 | 6.374.717 | 3,37% | Hisse senetleri |
| STATE STREET CORP | $422.513.141 | 5.980.370 | 3,16% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $377.544.673 | 5.351.464 | 2,83% | Hisse senetleri |
| Invesco Ltd. | $352.290.855 | 4.986.424 | 2,64% | Hisse senetleri |
| Ruane, Cunniff & Goldfarb L.P. | $236.595.617 | 3.348.841 | 1,77% | Hisse senetleri |
| SNYDER CAPITAL MANAGEMENT L P | $223.523.600 | 3.163.816 | 1,67% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $200.977.476 | 2.844.692 | 1,50% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $194.007.331 | 2.746.462 | 1,45% | Hisse senetleri |
| MAIRS & POWER INC | $190.804.299 | 2.700.698 | 1,43% | Hisse senetleri |
| Capital Research Global Investors | $185.236.529 | 2.621.890 | 1,39% | Hisse senetleri |
| UBS Group AG | $175.113.585 | 2.478.607 | 1,31% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $159.216.156 | 2.253.512 | 1,19% | Hisse senetleri |
| WHITEBOX ADVISORS LLC | $148.365.071 | 2.100.001 | 1,11% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $146.056.441 | 2.067.324 | 1,09% | Hisse senetleri |
| JPMORGAN CHASE & CO | $132.595.073 | 1.862.805 | 0,99% | Hisse senetleri |
| Amundi | $129.094.567 | 1.827.241 | 0,97% | Hisse senetleri |
| RGM Capital, LLC | $126.562.178 | 2.152.052 | 0,95% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $114.623.691 | 1.622.416 | 0,86% | Hisse senetleri |
| MAVERICK CAPITAL LTD | $108.490.847 | 1.535.610 | 0,81% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $104.625.879 | 2.002.026 | 0,78% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $100.035.859 | 1.410.943 | 0,75% | Hisse senetleri |
| NORGES BANK | $99.873.595 | 1.413.639 | 0,75% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $97.062.653 | 1.373.852 | 0,73% | Hisse senetleri |
| NORTHERN TRUST CORP | $92.635.432 | 1.311.188 | 0,69% | Hisse senetleri |
| BROWN ADVISORY INC | $90.965.942 | 1.287.558 | 0,68% | Hisse senetleri |
| Bank of New York Mellon Corp | $90.304.574 | 1.278.196 | 0,68% | Hisse senetleri |
| Madison Asset Management, LLC | $75.134.377 | 1.063.473 | 0,56% | Hisse senetleri |
| GENEVA CAPITAL MANAGEMENT LLC | $71.503.266 | 1.012.077 | 0,54% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $69.875.181 | 989.033 | 0,52% | Hisse senetleri |
| AMERICAN CAPITAL MANAGEMENT INC | $68.798.193 | 973.789 | 0,51% | Hisse senetleri |
| CITADEL ADVISORS LLC | $68.242.106 | 965.918 | 0,51% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $67.487.527 | 955.237 | 0,51% | Hisse senetleri |
| Stephens Investment Management Group LLC | $66.742.843 | 944.697 | 0,50% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $66.643.227 | 943.287 | 0,50% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $62.118.094 | 879.237 | 0,46% | Hisse senetleri |
| TIG Advisors, LLC | $59.500.865 | 842.192 | 0,45% | Hisse senetleri |
| Balyasny Asset Management L.P. | $59.124.866 | 836.870 | 0,44% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $56.587.061 | 797.001 | 0,42% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $55.795.484 | 789.745 | 0,42% | Hisse senetleri |
| CRAMER ROSENTHAL MCGLYNN LLC | $54.734.180 | 774.723 | 0,41% | Hisse senetleri |
| Magnetar Financial LLC | $53.829.012 | 761.911 | 0,40% | Hisse senetleri |
| AQR Arbitrage LLC | $53.825.974 | 761.868 | 0,40% | Hisse senetleri |
| Cresset Asset Management, LLC | $52.048.420 | 736.708 | 0,39% | Hisse senetleri |
Şirket yöneticileri 35 içeriden öğrenenler · 17 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kim Kelderman | Chief Executive Officer | 17 Ağustos 2026 A | 82.762 | 0 | 0 | $0 |
| Charles R. Kummeth | Chief Executive Officer | 15 Ağustos 2023 A | 1.278.269 | 0 | 0 | $0 |
| Thomas E Oland | CEO, President | 30 Kasım 2011 G | 1.177.420 | 0 | 0 | $0 |
| James Hippel | CFO | 17 Ağustos 2026 A | 170.183 | 0 | 0 | $0 |
| Gregory J Melsen | CFO | 01 Ağustos 2013 A | 1.438 | 0 | 0 | $0 |
| Steven C. Crouse | President - Diag & Spatial Bi | 17 Ağustos 2026 A | 10.237 | 0 | 0 | $0 |
| William Geist | PRESIDENT, PROTEIN SCIENCES | 17 Ağustos 2026 A | 24.943 | 0 | 0 | $0 |
| Matthew Mcmanus | President - Diag & Spatial Bio | 01 Şubat 2026 M | 7.691 | 0 | 0 | $0 |
| Norman David Eansor | President-Protein Sciences | 16 Kasım 2021 M | 2.117 | 0 | 0 | $0 |
| Shane Bohnen | SVP - General Counsel | 17 Ağustos 2026 A | 10.360 | 0 | 0 | $0 |
| Brenda S. Furlow | SVP - GENERAL COUNSEL | 08 Aralık 2022 M | 26.092 | 0 | 0 | $0 |
| Kevin S Gould | SVP Clinical Controls | 26 Ekim 2017 A | 1.355 | 0 | 0 | $0 |
| Robert M. Gavin | Sen. VP Protein Platforms | 26 Ekim 2017 A | 1.667 | 0 | 0 | $0 |
| Fernando J. Bazan | Chief Technical Officer | 26 Ekim 2017 A | · | 0 | 0 | $0 |
| Marcel Veronneau | SVP - Clinical Controls | 07 Ağustos 2015 A | 34.989 | 0 | 0 | $0 |
| Kevin J Reagan | Senior VP - Biotech | 09 Aralık 2014 M | 0 | 0 | 0 | $0 |
| Monica Tsang | VP of Research | 03 Mayıs 2007 S | 0 | 0 | 0 | $0 |
| John L Higgins | Yönetim kurulu üyesi | 28 Eylül 2026 M | 77.254 | 0 | 0 | $0 |
| Robert V Baumgartner | Yönetim kurulu üyesi | 22 Eylül 2026 M | 56.884 | 0 | 0 | $0 |
| Amy E. Herr | Yönetim kurulu üyesi | 17 Ağustos 2026 A | 576 | 0 | 2 | $-437.168 |
| Judith V. Klimovsky | Yönetim kurulu üyesi | 30 Ekim 2025 A | 3.782 | 0 | 0 | $0 |
| Alpna Seth | Yönetim kurulu üyesi | 30 Ekim 2025 A | 15.411 | 0 | 0 | $0 |
| Rupert Vessey | Yönetim kurulu üyesi | 30 Ekim 2025 A | 10.987 | 0 | 0 | $0 |
| Julie L Bushman | Yönetim kurulu üyesi | 30 Ekim 2025 A | 8.775 | 0 | 0 | $0 |
| Joseph D Keegan | Yönetim kurulu üyesi | 30 Ekim 2025 A | 15.411 | 0 | 0 | $0 |
| Roeland Nusse | Yönetim kurulu üyesi | 25 Ağustos 2025 M | 44.559 | 0 | 0 | $0 |
| Randolph C Steer | Yönetim kurulu üyesi | 26 Ekim 2023 A | 24.201 | 0 | 0 | $0 |
| Harold J Wiens | Yönetim kurulu üyesi | 29 Mayıs 2020 M | 4.843 | 0 | 0 | $0 |
| Charles A Dinarello | Yönetim kurulu üyesi | 08 Ağustos 2018 M | 8.212 | 0 | 0 | $0 |
| Roger C Lucas | Yönetim kurulu üyesi | 10 Ekim 2017 S | 1.870 | 0 | 0 | $0 |
| Karen A Holbrook | Yönetim kurulu üyesi | 06 Eylül 2017 S | 914 | 0 | 0 | $0 |
| Howard V Oconnell | Yönetim kurulu üyesi | 19 Şubat 2015 M | 70.000 | 0 | 0 | $0 |
| G A Herbert | Yönetim kurulu üyesi | 23 Ekim 2008 A | 0 | 0 | 0 | $0 |
| Christopher S Henney | Yönetim kurulu üyesi | 17 Eylül 2004 M | 0 | 0 | 0 | $0 |
| James A Weatherbee | · | 11 Ağustos 2004 M | 66.292 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 79 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,64% | 197.418 SH | 01 Ekim 2026 | Günlük |
| CVAR · ETF Opportunities Trust | 1,46% | 8.709 NS | 31 Temmuz 2026 | N-PORT |
| SMCO · Tidal Trust II | 1,23% | 24.154 NS | 31 Temmuz 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 1,18% | 15.133 NS | 31 Temmuz 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 0,96% | 33.399 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,83% | 1.192.234 SH | 11 Eylül 2026 | Günlük |
| HIBL · Direxion Shares ETF Trust | 0,80% | 8.362 NS | 31 Temmuz 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,72% | 21.025 NS | 31 Temmuz 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,44% | 20.095 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,34% | 125.077 SH | 01 Ekim 2026 | Günlük |
| BKMC · BNY Mellon ETF Trust | 0,30% | 26.966 NS | 31 Temmuz 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,30% | 2.074.464 SH | 19 Ağustos 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 69.377 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 78.263 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,22% | 28.839 SH | 11 Eylül 2026 | Günlük |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.707.457 SH | 01 Ekim 2026 | Günlük |
| ESML · iShares Trust | 0,20% | 77.713 SH | 11 Eylül 2026 | Günlük |
| IYH · iShares Trust | 0,18% | 91.322 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,16% | 74.551 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,16% | 470.400 SH | 19 Ağustos 2026 | Günlük |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 179.955 NS | 31 Temmuz 2026 | N-PORT |
| SMMD · iShares Trust | 0,16% | 83.492 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,15% | 326.736 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 0,14% | 82.099 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,13% | 3.592.334 SH | 19 Ağustos 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,13% | 3.081 NS | 31 Temmuz 2026 | N-PORT |
| IWS · iShares Trust | 0,11% | 233.699 SH | 11 Eylül 2026 | Günlük |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,11% | 283.007 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,11% | 9.898 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 10.469 SH | 01 Ekim 2026 | Günlük |
| IWR · iShares Trust | 0,08% | 642.446 SH | 11 Eylül 2026 | Günlük |
| XOEF · iShares Trust | 0,07% | 201 SH | 11 Eylül 2026 | Günlük |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 3.597 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,05% | 328.954 NS | 31 Temmuz 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,05% | 31.949 SH | 01 Ekim 2026 | Günlük |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 36.220 SH | 19 Ağustos 2026 | Günlük |
| IVE · iShares Trust | 0,04% | 260.926 SH | 11 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,04% | 11.899 NS | 31 Temmuz 2026 | N-PORT |
| IUSV · iShares Trust | 0,04% | 139.638 SH | 11 Eylül 2026 | Günlük |
| CHRI · Global X Funds | 0,03% | 38 NS | 31 Temmuz 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 24.046 SH | 11 Eylül 2026 | Günlük |
| IWD · iShares Trust | 0,03% | 347.001 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 94.334 SH | 19 Ağustos 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,03% | 13.560 NS | 31 Temmuz 2026 | N-PORT |
| EGLE · Global X Funds | 0,03% | 8 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 6.952 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 0,02% | 14 NS | 31 Temmuz 2026 | N-PORT |
| TOPC · iShares Trust | 0,02% | 94 SH | 11 Eylül 2026 | Günlük |
| XYLG · Global X Funds | 0,02% | 183 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 4.066.636 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 4.969.805 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 26.036 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 13.051 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,02% | 35.342 SH | 19 Ağustos 2026 | Günlük |
| XVV · iShares Trust | 0,02% | 1.844 SH | 11 Eylül 2026 | Günlük |
| XCLR · Global X Funds | 0,02% | 9 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 30.368 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 7.913 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 7.907 NS | 31 Temmuz 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 929 SH | 28 Eylül 2026 | Günlük |
| IVV · iShares Trust | 0,02% | 1.980.406 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,02% | 48.802 NS | 31 Temmuz 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 6.868 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,02% | 110.265 SH | 11 Eylül 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 0,02% | 591 NS | 31 Temmuz 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,02% | 3.773 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,02% | 110 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,02% | 205.546 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,02% | 43.086 SH | 10 Eylül 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 124 SH | 29 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,01% | 3.288 SH | 29 Eylül 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,01% | 1.089 NS | 31 Temmuz 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,01% | 12.240 NS | 31 Temmuz 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 129.171 SH | 19 Ağustos 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,01% | 21.082 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,01% | 8.387 SH | 01 Ekim 2026 | Günlük |
| ISCB · iShares Trust | · | 7.135 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 14.917 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 49.071 SH | 11 Eylül 2026 | Günlük |
TECH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 22 analist
TUT
Medyan hedef
$73.00
+0,8%
3 13,6%
Güçlü Al
4 18,2%
Al
15 68,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
11 analist · 2026-09-27Ortalama hedef $70.73 -2,3%
Şimdi
Mevcut fiyat $72.40
Düşük$50.00
Ortalama$70.73
Yüksek$73.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BIO | · | · | · | · | · | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
Son Haberler Bu şirketten bahseden son manşetler
Bio-Techne, Charles River Laboratories International'ı Geride Bırakarak 477. Sıraya Yerleşti
Nasdaq · 3 ay önce
Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
Yahoo Finance · 3 ay önce
Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger
Yahoo Finance · 3 ay önce
Germany’s Merck to Acquire Bio-Techne in $11.3 Billion Deal
Yahoo Finance · 3 ay önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-K dosyalandı Ağu 24, 2026